OTC Derivatives Clearing Summit: Industry will struggle to meet clearing deadlines

Buy-side firms will struggle to finish legal and operational work ahead of US mandated clearing deadlines – and they are not the only ones, says panel

stopwatch-its

Buy-side firms will find it difficult to meet Dodd-Frank Act deadlines to clear over-the-counter derivatives, in large part because of legal and operational obstacles, according to speakers at Risk's inaugural OTC Derivatives Clearing Summit in New York this morning.

The Commodity Futures Trading Commission (CFTC) published a proposed clearing determination for certain interest rate and credit default swaps on July 24, and a final rule is expected in October or early November. From that point

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Switching CCP – How and why?

As uncertainty surrounding Brexit continues and the impacts of Covid-19-driven market volatility are analysed, it is essential for banks and their end-users to understand their clearing options, and how they can achieve greater capital and cross…

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here